Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Extracted from the core of sandalwood trees (santalum album tree), sandalwood oil has been used for many centuries by several cultures throughout the world for perfume, soaps, incense and candles.

13 Feb 2024

Plant-based diet linked to less erectile dysfunction, urinary incontinence in prostate cancer patients

A diet that limits meat and dairy but is rich in fruits, vegetables, grains, and nuts is linked to less erectile dysfunction, urinary incontinence, and other common side effects seen in prostate cancer patients, a new study shows.

13 Feb 2024

Representation matters to Black patients seeking prostate cancer information online, study shows

For Black men with prostate cancer, racial representation is a key factor affecting trust in websites offering information on prostate cancer, reports a study in the March issue of The Journal of Urology, an Official Journal of the American Urological Association (AUA).

9 Feb 2024

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Once they enter the body, drugs, apart from carrying out their therapeutic function, are biochemically transformed by the action of the metabolic machinery, a process that facilitates their expulsion.

9 Feb 2024

Wayne State researchers secure $1.4 million DoD grant for prostate cancer study

A team of researchers from Wayne State University was awarded a $1.4 million, three-year grant from the U.S. Department of Defense for the study, "Cytochrome c acetylation drives prostate cancer aggressiveness and Warburg effect."

7 Feb 2024

Reducing unnecessary testing or treatments in older patients

When a doctor ordered a routine prostate screening for an 80-year-old man -; as doctors often do -; a dramatic yellow alert popped up on the electronic health record with dire warnings.

7 Feb 2024

New prostate cancer resource helps to better understand treatment options and outcomes

Every week, more than 400 men are diagnosed with prostate cancer.

7 Feb 2024

Boosting fitness levels linked to lower prostate cancer risk

A study in Swedish men finds that increasing cardiorespiratory fitness (CRF) over time is associated with a lower risk of prostate cancer incidence, highlighting the potential protective effects of improved fitness against this disease.

5 Feb 2024

Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells.

5 Feb 2024

PI3K/AKT and MEK/ERK pathways targeted in new therapy for docetaxel-resistant prostate cancer

A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumours Unit of the Institut Català d'Oncologia (ICO) and the Germans Trias i Pujol Research Institute (IGTP) have found a new therapeutic strategy for patients with a specific subtype of metastatic prostate cancer resistant to standard chemotherapy treatment with docetaxel.

5 Feb 2024

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in patients with renal cell carcinoma, as seen in the results of a large phase 3 clinical trial reported today at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in San Francisco, California.

29 Jan 2024

Penn analysis shows low risk of secondary cancers following CAR T cell therapy

The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine, researchers from the Perelman School of Medicine at the University of Pennsylvania reported today in Nature Medicine.

24 Jan 2024

Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found.

23 Jan 2024

Long-term prostate cancer treatment study informs decisions for diverse groups

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.

23 Jan 2024

Team approach to prostate cancer: PCPs and urologists offer hope with active surveillance

This study considers the perspectives of primary care physicians (PCPs) and urologists on what facilitates and what creates barriers to active surveillance (AS) care for men with low-risk prostate cancer.

22 Jan 2024

Rutgers researchers devise strategy to boost prostate cancer treatment efficacy

Rutgers researchers can predict which patients will benefit from a popular prostate cancer drug – and have devised a strategy that may make the treatment work longer.

22 Jan 2024

Study evaluates factors associated with selection of active surveillance for low-risk prostate cancer

Because low-risk prostate cancer is unlikely to spread or impact survival, experts and guidelines recommend active surveillance, which involves regular monitoring and thus avoid or delay treatment like surgery or radiation therapy and their life-changing complications.

22 Jan 2024

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Plant-based diet linked to less erectile dysfunction, urinary incontinence in prostate cancer patients

Representation matters to Black patients seeking prostate cancer information online, study shows

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Wayne State researchers secure $1.4 million DoD grant for prostate cancer study

Reducing unnecessary testing or treatments in older patients

New prostate cancer resource helps to better understand treatment options and outcomes

Boosting fitness levels linked to lower prostate cancer risk

Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

PI3K/AKT and MEK/ERK pathways targeted in new therapy for docetaxel-resistant prostate cancer

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

Penn analysis shows low risk of secondary cancers following CAR T cell therapy

Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Long-term prostate cancer treatment study informs decisions for diverse groups

Team approach to prostate cancer: PCPs and urologists offer hope with active surveillance

Rutgers researchers devise strategy to boost prostate cancer treatment efficacy

Study evaluates factors associated with selection of active surveillance for low-risk prostate cancer

Receptor protein found to be a key player in prostate cancer cells' drug resistance

UMass Amherst researcher aims to tackle bone damage in metastatic cancer

New study challenges role of rectal exam in prostate cancer screening

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in